Related Experiment Videos
Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use
M Massouh1, A Jatoi, E M Gordon
1Department of Medicine, University Hospital of Cleveland, OH 44106.
The Journal of Laboratory and Clinical Medicine
|December 1, 1989
Abstract:
Inhibition of thrombin by heparin is mediated by at least two plasma proteins, antithrombin III, and heparin cofactor II. The plasma titer of heparin cofactor II was significantly elevated in both pregnant women and users of oral contraceptives.
Keywords:
BiologyBlood Coagulation EffectsComparative StudiesContraceptionContraceptive AgentsContraceptive Agents, EstrogenContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive Methods--side effectsEndocrine SystemEstrogensEthinyl EstradiolFamily PlanningHematological EffectsHemic SystemHormonesNorethindroneOral Contraceptives, Combined--side effectsOral Contraceptives--side effectsPhysiologyPituitary HormonesPregnancyProlactinReproductionResearch MethodologyStudies